Navigation Links
Diabetes Patients with High Triglycerides and Low HDL Cholesterol Get the Most Benefit From Fenofibrate Treatment: New Data From the FIELD Study
Date:2/26/2009

te, argue for consideration of fenofibrate in the clinical management of patients with type 2 diabetes and marked atherogenic dyslipidemia.

Professor Richard O'Brien, a diabetes specialist and Clinical Dean of Medicine at the University of Melbourne, Austin and Northern Clinical Schools, added:

These findings on macrovascular disease build on earlier results of the FIELD trial showing clear benefits for patients with microvascular complications. Fenofibrate reduces the need for laser treatment in patients with diabetic disease in the small vessels of the eyes. It also reduces the risk of amputations resulting from disease in the small vessels of the limbs.

FIELD (5), a large international multicentre trial in which 9795 patients were followed up over 5 years, was coordinated at the NHMRC Clinical Trials Centre at the University of Sydney. Professor Anthony Keech, Professor of Medicine, Cardiology and Epidemiology and Deputy Director of the trials centre, is chair of the trial.

Notes for Editors

What is the FIELD study?

The FIELD trial was a randomised, double-blind, placebo-controlled study in 9795 patients with type 2 diabetes. The study evaluated whether treatment with fenofibrate (200 mg/day) for a median of 5 years could reduce macrovascular and microvascular complications of type 2 diabetes. Macrovascular study endpoints were major coronary events (primary) and total cardiovascular events (secondary). Microvascular endpoints were laser treatment for diabetic retinopathy, progression of albuminuria and non-traumatic lower-extremity amputation.

What were the key macrovascular findings in the FIELD study?

After a mean of 5 years treatment, fenofibrate was associated with a non-significant 11% reduction in the primary endpoint. However, there was a significant reduction in the secondary endpoint (reduction b
'/>"/>

SOURCE Solvay
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. February 2009 Mayo Clinic Womens HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus
2. MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
3. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
4. Epidemics of Both Type 1 Diabetes (Insulin Dependent) and Type 2 Diabetes (Obesity Related) Are Linked to Immunization
5. Overweight Siblings of Children With Type 2 Diabetes Likely to Have Abnormal Blood Sugar Levels
6. Patient Recruitment Begins in India for Phase 3 Diabetes Trial
7. Opportunities to Highlight Type 1 Diabetes in November
8. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
9. FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
10. TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program
11. Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that ... available in its catalogue: ... for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
(Date:1/14/2014)... North America,s leading business partnering event ... 30 th edition of its annual conference at the ... 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... specialty chemical companies will take part in the conference, which ...
(Date:1/14/2014)... NuAire , a manufacturer of ergonomically designed laboratory equipment ... of Japan to sell and service the ... NuAire will utilize its network of sales professionals throughout ... to offer assistance in application use, product benefits and features, options ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... Pa., April 16 ViroPharma Incorporated,(Nasdaq: VPHM ... a,division of Wyeth (NYSE: WYE ), have ... previously announced safety issue that emerged in the,ongoing ... "Clearly, this is a disappointing outcome for ...
... State Funding Led to Important Clinical Trials, ... agency overstated and hyped the importance of its ... treat a severe blood disorder,Consumer Watchdog said today, ... support publicly funded stem cell,research., Last week ...
Cached Medicine Technology:ViroPharma Announces Discontinuation of HCV-796 Development 2California Stem Cell Agency Exaggerated Its Role in Funding Key Research 2
(Date:4/17/2014)... University School of Medicine (BUSM) have discovered that ... an experimental model. The findings, reported in the ... , may lead to more effective treatments for ... of the leading causes of illness and death ... impact by limiting the productivity of workers and ...
(Date:4/17/2014)... by Cesar A. Arias, M.D., Ph.D., at The University ... identified a new superbug that caused a bloodstream infection ... April 17 issue of The New England Journal ... of a class of highly-resistant bacteria known as methicillin-resistant ... major cause of hospital and community-associated infections. The superbug ...
(Date:4/17/2014)... Massage therapy improves general blood flow and alleviates ... by researchers at the University of Illinois at ... of print in the Archives of Physical ... improved vascular function in people who had not ... regardless of their level of physical activity. , ...
(Date:4/17/2014)... adrenaline after they suffer a cardiac arrest outside of ... long-term, according to new research conducted at St. Michael,s ... a cardiac arrest get adrenaline, which has been the ... Dr. Steve Lin, an emergency physician and trauma team ... treatment, long-term survival rates of patients who suffer a ...
(Date:4/16/2014)... STANFORD, Calif. Consider the marvel of the embryo. It ... and function as they multiply to become the cells of ... of the body. , Now, in a feat of reverse ... complex genetic coding that allows embryonic cells to proliferate and ...
Breaking Medicine News(10 mins):Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:New MRSA superbug emerges in Brazil 2Health News:Massage therapy improves circulation, eases muscle soreness 2Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 3
... , HOUSTON, Nov. 18 Cyberonics, Inc. (Nasdaq: CYBX ... , Quarterly highlights , Results for the ... fiscal 2009 include: , Net sales of $40.7 million, a ... million, an increase of 101% over the prior year; U.S. ...
... , WASHINGTON, Nov. 18 Detroit resident Jaquita ... in U.S. District Court in Detroit to participating in ... Lanny A. Breuer of the Criminal Division, U.S. Attorney ... Daniel R. Levinson, Inspector General of the Department of ...
... complications no greater overall than for other women , WEDNESDAY, ... multiple sclerosis puts pregnant women at slightly higher risk for ... at a slower rate in the womb. , But ... Neurology , also reported that pregnant women with MS ...
... Beth Israel Deaconess Medical Center (BIDMC) neurologists ... been awarded grants totaling more than $1.5 million from ... to conduct investigations aimed at improving the quality of ... degenerative disorder of the nervous system that affects one ...
... , Preliminary report from the Harvard School of Public ... Nov. 18 Think your kids won,t eat healthy foods? Think ... the Harvard School of Public Health, funded by Project Bread, proves ... more of the healthy foods than they would if they were ...
... CLEVELAND, Nov. 18 Hospice workers have seen patients hang ... Researchers from the Frances Payne Bolton School of Nursing and ... University will study what drives the dying to resolve unfinished ... Jo Prince-Paul from nursing and Julie Exline from arts and ...
Cached Medicine News:Health News:Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter 2Health News:Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter 3Health News:Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter 4Health News:Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter 5Health News:Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter 6Health News:Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter 7Health News:Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter 8Health News:Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter 9Health News:Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter 10Health News:Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter 11Health News:Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter 12Health News:Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter 13Health News:Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter 14Health News:Occupational Therapist and Patient Recruiter Plead Guilty in Detroit-Based Medicare Fraud Schemes 2Health News:Occupational Therapist and Patient Recruiter Plead Guilty in Detroit-Based Medicare Fraud Schemes 3Health News:MS Need Not Preclude Pregnancy 2Health News:BIDMC scientists awarded grants from Michael J. Fox Foundation for Parkinson's research 2Health News:New Study Proves Kids Like Eating Healthy Food 2Health News:New Study Proves Kids Like Eating Healthy Food 3Health News:Research Collaboration Focuses on Unfinished Business at the End of Life 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: